Quantcast

Latest AstraZeneca Stories

2014-09-30 08:31:20

ROCKVILLE, Md., Sept. 30, 2014 /PRNewswire-USNewswire/ -- Accelovance, Inc. (Accelovance), a contract research organization (CRO) focusing in early phase oncology, vaccines, and general medicine, today announced that Dr. Joseph D. Purvis has joined the company as Vice President Medical Affairs, Oncology. http://photos.prnewswire.com/prnvar/20140219/DC68221LOGO "I'm excited to announce Dr. Purvis' addition to our company, his expertise will be invaluable as we continue our growth...

2014-09-29 00:20:31

BASEL, Switzerland, Sept. 29, 2014 /PRNewswire/ -- Syngenta today announced that John Atkin, Chief Operating Officer, will retire from the company at the end of 2014. He will be succeeded by Jon Parr, who will assume responsibility for two of the company's four regions: Europe, Africa and the Middle East and Latin America. North America and Asia Pacific will remain under the leadership of Davor Pisk, Chief Operating Officer. Jon Parr has worked for Syngenta and its legacy companies...

2014-09-26 08:25:31

SAN FRANCISCO, Sept. 26, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of MOVENTIG® (naloxegol) for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxatives. MOVENTIG is an investigational, peripherally-acting...

2014-09-25 12:29:32

DUBLIN, Sept. 25, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical industry,...

2014-09-25 08:27:49

BUENA, N.J., Sept. 25, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and records for 18 drug products from AstraZeneca, 17 of which were marketed. The acquisition includes the regulatory rights and documents for 17 injectable products and 1 suppository product. All of these products had been previously approved by the US FDA as...

2014-09-24 08:28:24

Launched in Conjunction with Thyroid Cancer Awareness Month, aMTCSupport.com Offers Resources and Support for Rare Disease Community WILMINGTON, Del., Sept. 24, 2014 /PRNewswire/ -- In the United States for 2014, about 62,900 new thyroid cancer cases will be diagnosed. Medullary thyroid cancer - a rare form of cancer located in the thyroid gland at the base of the throat - represents only about three to four percent of all thyroid cancers. Of those cases, just one third will be...

2014-09-23 08:30:28

#MBCStrength Encourages Women Living with Metastatic Breast Cancer to Share their Strength and Inspiration with Others WILMINGTON, Del., Sept. 23, 2014 /PRNewswire/ -- More than 173,000 women in the United States are living with metastatic breast cancer and each has a story to tell. AstraZeneca is launching a nationwide photo-sharing campaign to provide them another way to share their inspiration, experiences and strengths with others. To view the multimedia assets associated with...

2014-09-20 23:02:18

LifeScienceIndustryResearch.com adds “Symbicort (Asthma) - Forecast and Market Analysis to 2023” to its store. Report provides Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan and Australia. Dallas, TX (PRWEB) September 20, 2014 New PharmaPoint Drug Evaluation report, “Symbicort (Asthma) – Forecast and Market Analysis to 2023″. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious...

2014-09-19 16:24:14

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fg8h7p/global) has announced the addition of the "Global Endometriosis Market 2014-2018" [http://www.researchandmarkets.com/research/fg8h7p/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Endometriosis is a common female health condition where the endometrial tissue, which is usually found inside the lining...

2014-09-19 00:21:26

BASEL, Switzerland, Sept. 19, 2014 /PRNewswire/ -- -- Global network of over 3,500 farms established to measure productivity -- First independently-audited data to be published in March 2015 -- Projects underway in all regions; partnerships agreed and expanded Syngenta today provided an update on the progress of The Good Growth Plan one year after its launch in September 2013. The Plan comprises six measurable commitments for the year 2020 to help address the global food...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related